ATE264093T1 - Sojazubereitungen und deren verwendung zur gesundheitsförderung - Google Patents

Sojazubereitungen und deren verwendung zur gesundheitsförderung

Info

Publication number
ATE264093T1
ATE264093T1 AT99938755T AT99938755T ATE264093T1 AT E264093 T1 ATE264093 T1 AT E264093T1 AT 99938755 T AT99938755 T AT 99938755T AT 99938755 T AT99938755 T AT 99938755T AT E264093 T1 ATE264093 T1 AT E264093T1
Authority
AT
Austria
Prior art keywords
present
soy
formulation
formulations
pharmacological compositions
Prior art date
Application number
AT99938755T
Other languages
English (en)
Inventor
Aaron Tabor
Original Assignee
Aaron Tabor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26786272&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE264093(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aaron Tabor filed Critical Aaron Tabor
Application granted granted Critical
Publication of ATE264093T1 publication Critical patent/ATE264093T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
    • A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Agronomy & Crop Science (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
AT99938755T 1998-07-16 1999-07-16 Sojazubereitungen und deren verwendung zur gesundheitsförderung ATE264093T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9298598P 1998-07-16 1998-07-16
US10579798P 1998-10-27 1998-10-27
PCT/US1999/016203 WO2000003684A2 (en) 1998-07-16 1999-07-16 Soy formulations and their use for promoting health

Publications (1)

Publication Number Publication Date
ATE264093T1 true ATE264093T1 (de) 2004-04-15

Family

ID=26786272

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99938755T ATE264093T1 (de) 1998-07-16 1999-07-16 Sojazubereitungen und deren verwendung zur gesundheitsförderung

Country Status (9)

Country Link
US (2) US6482448B2 (de)
EP (1) EP1037590B1 (de)
CN (1) CN1184895C (de)
AT (1) ATE264093T1 (de)
AU (1) AU773631B2 (de)
CA (1) CA2313789A1 (de)
DE (1) DE69916414T2 (de)
ES (1) ES2220102T3 (de)
WO (1) WO2000003684A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0862445B2 (de) * 1995-10-06 2017-03-22 Arch Development Corporation Kombination von Herpes simplex Virus und Chemotherapie für Krebstherapie
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5821361A (en) * 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
WO2001028356A2 (en) * 1999-10-18 2001-04-26 Muscletech Research And Development Inc. Food supplement for increasing lean mass and strength
CA2398445C (en) * 2000-02-01 2012-04-03 Stevia Aps A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
AU2001253070A1 (en) * 2000-03-31 2001-10-15 Jonathan Ingram Isoflavones for treatment of obesity
FR2813790B1 (fr) * 2000-09-11 2004-03-12 Dolisos Lab Preparations pharmaceutiques contenant des extraits d'isoflavone de soja et des micro-organismes probiotiques
US7429399B2 (en) * 2001-06-18 2008-09-30 Solae, Llc Modified oilseed material
US20040219281A1 (en) * 2000-11-21 2004-11-04 Cargill, Incorporated Modified oilseed material
US20020160079A1 (en) * 2001-02-28 2002-10-31 Kim Tae-Hyun Koji produced from soybean hypocotyl, preparation method thereof, and soy hypocotyl products prepared from said koji
US20030150012A1 (en) * 2001-06-13 2003-08-07 Odell Joan T. Method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant
ATE541569T1 (de) 2001-07-24 2012-02-15 Cargill Inc Verfahren zur isolation von phenolischen verbindungen
US6787151B2 (en) 2001-08-10 2004-09-07 Lipton, Division Of Conopco, Inc. Composition for lowering blood cholesterol
MXPA04006017A (es) * 2001-12-20 2005-06-08 Femmepharma Inc Suministro de farmacos por via vaginal.
ITMI20020665A1 (it) * 2002-03-29 2003-09-29 Marfarma S R L Composizioni fluide per uso vaginale
US20060251750A1 (en) * 2002-09-30 2006-11-09 Tabor Aaron T Soy formulations and their use in skin care
AU2007216882B2 (en) * 2003-01-02 2010-03-11 Femmepharma Holding Company, Inc. Pharmaceutical preparations for treatment of diseases and disorders of the breast
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
EP1578421A4 (de) * 2003-01-02 2009-04-22 Femmepharma Holding Co Inc Pharmazeutische präparate für diebehandlung von erkrankungen und pathologischen zuständen der brust
US7022355B2 (en) * 2003-05-08 2006-04-04 Solae, Llc Composition and process for the production of a vegetable protein composition containing an alkaline earth metal salt
US7718813B2 (en) 2003-08-15 2010-05-18 Nature Pure Labs Sw, Inc. Hydrolysis and purification of active plant compounds suitable for topical application
CA2564443C (en) * 2004-05-10 2016-04-26 Instituto Tecnologico Y De Estudios Superiores De Monterrey (Itesm) Cancer cell growth inhibition by black bean (phaseolus vulgaris l) extracts
US20060009430A1 (en) * 2004-07-01 2006-01-12 Kelly Gregory J Composition for the prevention and treatment of the detrimental effects of dihydrotestosterone
US20060188548A1 (en) * 2004-12-14 2006-08-24 Mattson Peter H Satiety promoting beverage and use in a diet to moderate food consumption
CA2613788C (en) * 2005-06-29 2016-08-23 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatment of kidney disease
KR20090029237A (ko) 2006-06-02 2009-03-20 피어 트리 파머슈티칼스 인코포레이티드 위축성 질염을 치료하는 방법
WO2008031439A2 (en) * 2006-09-15 2008-03-20 Stevia Aps Treatment of insulin resistance or diseases associated with insulin resistance with bicyclo [ 3.2. i ]octans such as steviol and isosteviol
WO2008083158A2 (en) * 2006-12-26 2008-07-10 Femmepharma Holding Company, Inc. Topical administration of danazol
JP2010518164A (ja) * 2007-02-14 2010-05-27 マース インコーポレーテッド 神経性化合物
US20100068334A1 (en) * 2008-09-12 2010-03-18 Damon Randolph Race Medicinal Food and Beverage Compositions and Related Methods for Managing Acne in Humans
MX2011002983A (es) * 2008-09-19 2011-04-11 Nestec Sa Soporte nutricional para prevenir o moderar la paralisis de medula osea o neutropenia durante el tratamiento anti-cancer.
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
EP2822653B1 (de) * 2012-03-09 2024-06-19 Faculdade De Ciências da Universidade de Lisboa Neue c-glycosylpolyphenol-antidiabetika, wirkung auf glucosetoleranz und interaktion mit beta-amyloid therapeutische anwendungen synthetisierter mittel und von genista-tenera-ethylacetat-extrakten mit einigen dieser mittel
WO2021064107A1 (en) * 2019-10-02 2021-04-08 Norvia Nutrition Ltd. Composition comprising soy and use thereof in the prevention and/or treatment of microvascular or lipoprotein related diseases, microcardiovascular diseases, atherosclerosis, hypertension, and in patients with such cardiovascular disorders suffering from alzheimer and dementia, overweight and obesity, type 2 diabetes, asthma and other disorders

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864362A (en) 1970-05-27 1975-02-04 Chinoin Gyogyszer Es Vegyeszet Iso flavones
BR9306393A (pt) * 1992-05-19 1998-09-15 Graham Edmund Kelly Suplemento natural e processo para melhorar a saúde de um ser humano
TW274550B (de) 1992-09-26 1996-04-21 Hoechst Ag
CA2160371A1 (en) 1993-04-16 1994-10-27 The Trustees Of Tufts College Method for treatment of menopausal and premenstrual symptoms
US5506211A (en) 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US5424331A (en) 1994-06-10 1995-06-13 Bio-Virus Research Incorporated Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis
US5516528A (en) 1995-01-13 1996-05-14 Wake Forest University Dietary phytoestrogen in estrogen replacement therapy
US5569459A (en) 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
US5523087A (en) 1995-02-15 1996-06-04 Bio-Virus Research Incorporated Pharmaceutical compositions for the treatment of diabetic male sexual dysfunction
US5707630A (en) 1996-01-04 1998-01-13 Sabina International, Ltd. Herbal compound for relief of PMS through menopausal symptoms
CN1226805A (zh) * 1996-04-09 1999-08-25 纳幕尔杜邦公司 新型富含异黄酮的大豆蛋白产品及其生产方法
US5821361A (en) * 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
US5654011A (en) 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US6040333A (en) * 1996-07-30 2000-03-21 Energetics, Inc. Dietary supplements
JP2829387B2 (ja) 1996-09-13 1998-11-25 農林水産省四国農業試験場長 脂肪細胞における脂肪分解促進用組成物
US5733926A (en) 1996-12-13 1998-03-31 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
US6083526A (en) 1997-05-22 2000-07-04 Gorbach; Sherwood L. Use of isoflavonoids in the treatment or prevention of postpartum depression
US6060070A (en) 1997-06-11 2000-05-09 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of aging skin and wrinkles
US5855892A (en) * 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
US5952374A (en) 1997-09-29 1999-09-14 Protein Technologies International, Inc. Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function
US5942539A (en) 1997-10-03 1999-08-24 Wake Forest University Methods of treating or preventing endometriosis with phytoestrogens
US6132795A (en) * 1998-03-15 2000-10-17 Protein Technologies International, Inc. Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material

Also Published As

Publication number Publication date
US20020103223A1 (en) 2002-08-01
EP1037590A2 (de) 2000-09-27
CN1277540A (zh) 2000-12-20
CN1184895C (zh) 2005-01-19
DE69916414D1 (de) 2004-05-19
ES2220102T3 (es) 2004-12-01
US20030021859A1 (en) 2003-01-30
DE69916414T2 (de) 2005-05-19
US6482448B2 (en) 2002-11-19
WO2000003684A2 (en) 2000-01-27
AU773631B2 (en) 2004-05-27
EP1037590B1 (de) 2004-04-14
CA2313789A1 (en) 2000-01-27
AU5316899A (en) 2000-02-07
WO2000003684A3 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
DE69916414D1 (de) Sojazubereitungen und deren verwendung zur gesundheitsförderung
EP0903143A3 (de) Verwendung von Daidzein zur Herstellung eines Arzneimittels zur Erhöhung des HDL Cholesterolniveaus
DE60029797D1 (de) Zusammensetzungen und therapeutische anwendungen von isoflavonen und deren analoga
PL368976A1 (en) Composition for lowering blood cholesterol
ATE253921T1 (de) Kombinationen aus calzium und vitamin d
ATE215320T1 (de) Nahrungszusammensetzungen in verschiedenen formen
AU5079600A (en) Composition comprising ozonized oils and/or other ozonized natural and/or synthetic products and their use in pharmaceutical, cosmetic, dietetic or food supplement compositions in human and veterinary medicine
DK1032363T3 (da) Leveringssystem med konjugeret linolsyre i kosmetiske præparater
IL162590A0 (en) Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
ATE367810T1 (de) Zusammensetzung zur prävention von osteoporose bestehend aus einer kombination aus isoflavonen und polyungesättigten fettsäuren
BG106155A (en) Novel derivatives and analogues of galanthamin
BRPI0110757B8 (pt) composição, suplemento dietético, composição farmacêutica, e, processo para a manufatura de uma composição farmacêutica
IL141325A0 (en) Tan-1057 derivatives
ATE275409T1 (de) Zusammensetzung enthaltend verbindungen mit adrenergischer aktivität und pflanzliche extrakten von crataegus und gingko zur behandlung von übergewicht und fettleibigkeit
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives
MY135460A (en) Method of stimulating hair growth using benzopyrans
ATE304374T1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
DE502004007506D1 (de) Formulierung auf phospholipidbasis
DE50310932D1 (de) Sporopollenin enthaltende lösliche zusammensetzung und verwendung
WO2002072035A3 (en) Novel anti-inflammatory compositions and methods of use
DE60214881D1 (de) Zubereitungen zur behandlung von lupus
BR9914895A (pt) Composições compreendendo uma mistura de bioflavonóis
WO2003040119A8 (fr) Inhibiteurs de l'angiogenese
DE60236045D1 (de) Anwendungen von Tocopherolestern
ITMI20000197A0 (it) Procedimento per la produzione di componenti per integratori alimentari formulazioni dietetiche cosmetiche e farmaceutiche derivati da semi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties